Delivery Order SPE2DB24D2101-SPE2DB25FKPVW
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $17,777.00 for 100 mg vials of Enhertu, a oncology therapeutic agent used in cancer treatment. This firm fixed-price, competitively awarded contract was issued by the Defense Logistics Agency Medical Supply Chain on August 14, 2025, with a completion date of September 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Enhertu 100 mg vials, a specialty oncology pharmaceutical. This firm fixed-price delivery order, valued at $8,888.50 with an ultimate completion date of August 20, 2025, represents a non-competitive set-aside transaction under AmerisourceBergen's existing contract vehicle. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Enhertu 100 mg vials, a specialized oncology medication. This competitively awarded, non-set-aside delivery order carries a firm fixed price ceiling value of $10,666.20 and is scheduled for completion by August 13, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,443.90 for 100 mg vials of Enhertu, a oncology therapeutic agent, with performance in Conshohocken, Pennsylvania and completion scheduled for May 13, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. This delivery order executes...
- This delivery order, valued at $17,777, was awarded on July 22, 2025, to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials under a firm fixed-price arrangement. The contract is a non-set-aside award issued by the Medical Supply Chain, a Defense-focused federal agency, with a completion deadline of August 12, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,110.80 by the Defense Logistics Agency for 100 milligram vials of Enhertu, a prescription oncology medication. The contract, awarded on August 26, 2025, with completion targeted for September 17, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded through open...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Enhertu 100 mg vials, a specialized oncology pharmaceutical. This competitively awarded, non-set-aside contract has a ceiling value of $17.8K and a firm fixed price structure, with performance scheduled for completion by October 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Enhertu 100 mg vials, a specialized oncology medication. This firm fixed-price delivery order, valued at $5,333.10, represents a non-set-aside competitive award with performance scheduled through June 24, 2025. The award will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8,888.50 to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials, with an ultimate completion date of October 9, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $8,888.50 to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials, with an ultimate completion date of October 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on September 16, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPVWDelivery Order
AmerisourceBergen Drug Corp received a $17,777 firm fixed price delivery order from the Defense Logistics Agency (DLA) on September 23, 2025, for 100 mg vials of Enhertu, a oncology pharmaceutical product. The contract, with an ultimate completion date of October 15, 2025, represents a direct delivery order without a set-aside designation, awarded through competitive procedures. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The current award reflects the company's role as a critical federal pharmaceutical distributor fulfilling specialized oncology medication needs for defense medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 9/23/25 |